(Q33895391)

29 July 2017

title

Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections (English)

1 reference

29 July 2017

1 reference

1 reference

7

Jan Palmblad

1 reference

29 July 2017

5

Bengt Fadeel

1 reference

29 July 2017

Daniel Tesfa

1

1 reference

29 July 2017

Sofia Ajeganova

2

1 reference

29 July 2017

Hans Hägglund

3

1 reference

29 July 2017

Birgitta Sander

4

1 reference

29 July 2017

Ingiäld Hafström

6

1 reference

29 July 2017

language of work or name

1 reference

1 August 2011

1 reference

29 July 2017

published in

Arthritis & Rheumatology

1 reference

29 July 2017

volume

63

1 reference

29 July 2017

issue

8

1 reference

29 July 2017

page(s)

2209-2214

1 reference

Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature

29 July 2017

cites work

1 reference

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

21 January 2018

1 reference

Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis

21 January 2018

1 reference

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis

21 January 2018

1 reference

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.

21 January 2018

1 reference

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

21 January 2018

1 reference

Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.30427

1 reference

29 July 2017

1 reference